Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results